Nick Connis
Impact in
-
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
-
- Cancer therapeutics and mechanisms
- Epigenetics and DNA Methylation
- RNA Interference and Gene Delivery
- Protein Degradation and Inhibitors
Papers in
-
- Cell death mechanisms and regulation 2
- Epigenetics and DNA Methylation 1
- Glycosylation and Glycoproteins Research 1
- Histone Deacetylase Inhibitors Research 1
- Oncology 6
- Lung Cancer Research Studies 4
- Co-authors
- Christine L. Hann (9 shared papers)Charles M. Rudin (3 shared papers)John T. Poirier (2 shared papers)Eric E. Gardner (2 shared papers)Elisa de Stanchina (1 shared paper)André L. Moreira (1 shared paper)Gary L. Gallia (3 shared papers)Chandrashekhar D. Kamat (2 shared papers)
- Journals
- Molecular Cancer Therapeutics (3 papers)Pharmacology Biochemistry and Behavior (1 paper)Cancers (1 paper)PLoS ONE (1 paper)Anticancer Research (1 paper)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Nick Connis
11 papers receiving 402 citations
Peers
Comparison fields: 5 of 57
- Oncology 175
- Molecular Biology 226
- Epidemiology 81
- Rheumatology 34
- Cancer Research 31
Countries citing papers authored by Nick Connis
This map shows the geographic impact of Nick Connis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nick Connis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nick Connis more than expected).
Fields of papers citing papers by Nick Connis
This network shows the impact of papers produced by Nick Connis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nick Connis. The network helps show where Nick Connis may publish in the future.
Co-authors
The 25 scholars most cited alongside Nick Connis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 171 | |
| 2 | 2014 | 45 | |
| 3 | 2013 | 41 | |
| 4 | 2013 | 35 | |
| 5 | 2011 | 32 | |
| 6 | 2023 | 31 | |
| 7 | 2019 | 21 | |
| 8 | 2013 | 12 | |
| 9 | 2021 | 12 | |
| 10 | 2021 | 5 | |
| 11 | 2024 | 4 |
About Nick Connis
Nick Connis is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Rheumatology and Surgery, having authored 11 papers that have together received 409 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (4 papers), Sarcoma Diagnosis and Treatment (2 papers), Cell death mechanisms and regulation (2 papers), Bone Tumor Diagnosis and Treatments (2 papers), Epigenetics and DNA Methylation (1 paper), Glycosylation and Glycoproteins Research (1 paper), Histone Deacetylase Inhibitors Research (1 paper) and Animal Ecology and Behavior Studies (1 paper). The work is most often cited by research in Oncology (175 citations), Molecular Biology (226 citations), Epidemiology (81 citations), Rheumatology (34 citations) and Cancer Research (31 citations). Nick Connis has collaborated with scholars based in United States, China and France. Frequent co-authors include Christine L. Hann, Charles M. Rudin, John T. Poirier, Eric E. Gardner, Elisa de Stanchina, André L. Moreira, Gary L. Gallia, Chandrashekhar D. Kamat, Lucille A. Lumley and Ron B. Shmueli. Their work appears in journals such as Molecular Cancer Therapeutics, Pharmacology Biochemistry and Behavior, Cancers, PLoS ONE and Anticancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.